Return to Trial Database

MM08-141

A Phase I/II Trial of Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed or Refractory Multiple Myeloma: Hoosier Cancer Research Network MM08-141

Status

Study Completed

Cancer Type(s)

Mutiple Myeloma

Study Contact

Trial Locations

All sites in which the trial MM08-141 being conducted in.

No data was found